Molecular and genomic aspects of xenogenizing-alkylating drugs.
Allegrucci
M
M
Department of Experimental Medicine and Biochemical Science, University of Perugia, Italy.
Grohmann
U
U
Fuschiotti
P
P
Bianchi
R
R
Puccetti
P
P
Fioretti
M C
MC
D000477:Alkylating Agents / Q000493:pharmacokinetics / Q000633:toxicity*; D000818:Animals; D000951:Antigens, Neoplasm / Q000187:drug effects / Q000276:immunology; D002176:Candida albicans / Q000235:genetics / Q000276:immunology; D016521:Electrophoresis, Gel, Pulsed-Field; D051379:Mice; D009369:Neoplasms / Q000139:chemically induced / Q000235:genetics / Q000276:immunology*; D012441:Saccharomyces cerevisiae / Q000235:genetics / Q000276:immunology; D015262:Xenobiotics / Q000493:pharmacokinetics / Q000633:toxicity*
D000477:Alkylating Agents; D000951:Antigens, Neoplasm; D015262:Xenobiotics